Carrageenan: an asset or detriment in infant formula?
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND: Variation in the bioavailability of calcium (Ca), iron (Fe), and zinc (Zn) occurs because of interactions of food components in the gastrointestinal microenvironment. Bioavailability is preferably determined by in vivo tests, but these are expensive, labor-intensive, time consuming, and often unethical. As an alternative, in vitro methods can be used to predict bioavailability of nutrients from foodstuffs. METHODS: A continuous-flow dialysis model with preliminary intraluminal digestive phase, adapted to the gastrointestinal conditions of infants younger than 6 months, was used. Human milk was the reference standard. Ca, Fe, and Zn content of samples and dialysates after digestion were analyzed by atomic absorption spectrometry. RESULTS: Ca availability is similar in human milk (13.1%+/-0.8%), whey (13.3%+/-1.2%), and soy-based formulae (13.0%+/-1.2%; P > 0.05), and higher in casein-predominant formula (21.2%+/-0.6%; P < 0.05). Availability of Fe is highest in human milk (8.12%+/-0.27%: P < 0.05). Fe availability in whey (1.28%+/-0.28%) and soy formulae (1.48%+/-0.28%) is similar (P > 0.05), but availability is lower in casein-predominant formula (0.48%+/-0.22%; P < 0.05). Zn availability is also highest in human milk (13.1%+/-0.7%; P < 0.05). However, Zn availability is similar in whey (6.7%+/-0.6%) and casein formulae (8.5%+/-1.6%; P > 0.05), but lower in soy formula (2.3%+/-0.4%; P < 0.05). CONCLUSIONS: Our observations are in agreement with previous data from in vivo studies in term infants. This in vitro procedure is an inexpensive, simple, rapid, and reliable method that predicts the bioavailability of Ca, Fe, and Zn in foods.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Biopterin and neopterin concentrations were measured by reverse-phase high pressure liquid chromatography in milks of man, cow, rabbit, cat, and rat and in commercial formulas widely used in North America. There was wide variation of concentration among species. Higher concentrations of biopterin were present in human milk (392.0 +/- 158.6 pmol/ml) than were present in all milk formulas analyzed (2.6-50.6 pmol/ml).
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.